Special ReportA standardized definition of placental infection by SARS-CoV-2, a consensus statement from the National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development SARS-CoV-2 Placental Infection Workshop
Key words
Cited by (0)
D.J.R., A.G.E., and R.J.R. share first authorship.
Meeting date: March 9, 2021.
D.J.R. received royalties for authorship on perinatal pathology topics for UpToDate and Cambridge University Press, neither of which should impact this manuscript. J.L.H. is a consultant for Aadi Bioscience and TRACON Pharmaceuticals, unrelated to the topic of this manuscript. D.T.T. is a consultant for ROME Therapeutics, NanoString Technologies, Pfizer, Merrimack Pharmaceuticals, Ventana Roche, Foundation Medicine, Inc, and EMD Millipore Sigma, which are not related to this work. D.T.T. is a founder and has equity in ROME Therapeutics, PanTher Therapeutics, and TellBio, Inc, which is not related to this work. D.T.T. receives sponsored research support from ACD Bio-Techne for RNA in situ hybridization, which is related to this manuscript. D.T.T.’s interests were reviewed and are managed by Mass General Brigham in accordance with their conflict of interest policies. T.D.M. is a site principal investigator (PI) and medical consultant for a Pfizer trial of SARS-CoV-2 vaccination in pregnancy. T.D.M. receives UpToDate royalties and was the site PI for a Novavax and GestVision trial, which are unrelated to this work. The remaining authors report no conflict of interest.
This research was supported, in part, by the Perinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, United States Department of Health and Human Services (NICHD/NIH/DHHS), and, in part, with federal funds from NICHD/NIH/DHHS under contract number HHSN275201300006C. R.J.R. has contributed to this work as part of his official duties as an employee of the United States Federal Government.
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.